Top News

STAMFORD, Conn., Oct. 09, 2023 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic...

Green Brick Partners, Inc. and Century Communities Announce New Land Acquisition in Austin, Texas

AUSTIN, Texas, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Green Brick Partners and Century Communities today announced a new joint development...

Stryker to host investor day

Kalamazoo, Michigan, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host an Investor Day on Wednesday,...

Akero Therapeutics to Present Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis Due to NASH

Investor webcast on Tuesday, October 10 at 8:00 a.m. ET to present clinical dataSOUTH SAN FRANCISCO, Calif., Oct. 09, 2023...

Venus Concept to Release Third Quarter of Fiscal Year 2023 Financial Results on November 14, 2023

TORONTO, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical...

LifeVantage “All In” Global Convention 2023 Showcases Next Phases of LV360, Consultant Training, Product Reveals, New Sales Incentives, and More

Convention hosted in San Antonio, TX, October 5-7, attended by over 2,000 Independent Consultants from around the worldSALT LAKE CITY,...

Ventyx Biosciences Announces Positive Results from the Phase 2 Trial of VTX002 in Patients with Moderate-to-Severely Active Ulcerative Colitis

VTX002 60 mg achieved the primary endpoint of clinical remission with a high rate of complete endoscopic remission Both 30...

INPEFA® (Sotagliflozin) Receives Preferred Formulary Status With Express Scripts For Medicare Patients

INPEFA recently approved by FDA for treatment of heart failure Express Scripts has determined that it will list INPEFA as...

Mesa Airlines Launches Independent Pilot Time Building Program for Aspiring Pilots